Rezolute, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
RZLT Nasdaq 2830 www.rezolutebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rezolute, Inc.

Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism - Oct 14th, 2026 2:05 pm
Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’ - Oct 5th, 2026 6:58 am
Rezolute Says FDA Recommends Pre-BLA Meeting for Congenital Hyperinsulinism Treatment - Oct 5th, 2026 6:04 am
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism - Oct 5th, 2026 5:00 am
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update - Sep 24th, 2026 2:05 pm
Sector Update: Healthcare Stocks Softer Late Afternoon - Sep 9th, 2026 1:49 pm
Sector Update: Healthcare Stocks Decline in Afternoon Trading - Sep 9th, 2026 11:34 am
Rezolute FDA Review Continues After Phase 3 sunRIZE Study Missed Primary Endpoint - Sep 9th, 2026 8:43 am
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism - Sep 9th, 2026 5:00 am
Rezolute to Participate in Upcoming Investor Conferences - Sep 2nd, 2026 5:30 am
Rezolute to Participate in the BTIG Virtual Biotechnology Conference - Jul 21st, 2026 5:30 am
Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society - Jun 17th, 2026 5:00 am
Exploring 3 High Growth Tech Stocks in US Market - Jun 15th, 2026 5:39 am
Positive Signs As Multiple Insiders Buy Rezolute Stock - Jun 10th, 2026 5:46 am
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week? - Jun 4th, 2026 9:58 am
Rezolute Announces Four Presentations at the Upcoming Annual Meeting of the Endocrine Society - Jun 4th, 2026 5:30 am
Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls - Jun 3rd, 2026 7:55 am
Rezolute’s stock up on interim Phase III tumour HI data - Jun 3rd, 2026 5:47 am
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism - Jun 2nd, 2026 5:00 am
High Growth Tech Stocks in US for May 2026 - May 14th, 2026 5:38 am